Oxbridge Re Holdings Limited (NASDAQ:OXBR) Sees Large Decrease in Short Interest

Oxbridge Re Holdings Limited (NASDAQ:OXBR) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totaling 41,747 shares, a decrease of 63.2% from the August 15th total of 113,543 shares. Based on an average daily trading volume, of 9,235 shares, the days-to-cover ratio is presently 4.5 days. Currently, 0.6% of the company’s stock are sold short.

Oxbridge Re Stock Performance

Oxbridge Re stock traded down $0.06 during mid-day trading on Tuesday, reaching $1.44. 3,311 shares of the company were exchanged, compared to its average volume of 268,238. The business has a fifty day moving average of $1.42 and a 200 day moving average of $1.11. The firm has a market cap of $11.68 million, a P/E ratio of 71.79 and a beta of 1.97. Oxbridge Re has a 12-month low of $0.66 and a 12-month high of $2.86.

Oxbridge Re (NASDAQ:OXBR) last announced its quarterly earnings results on Thursday, August 13th. The insurance provider reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). The company had revenue of $0.94 million during the quarter, compared to analysts’ expectations of $1.10 million. Oxbridge Re had a net margin of 4.71% and a return on equity of 2.14%. Sell-side analysts predict that Oxbridge Re will post -0.08 EPS for the current year.

Analyst Ratings Changes

Several research firms recently weighed in on OXBR. Weiss Ratings upgraded Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a report on Friday, August 14th. Maxim Group dropped their target price on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating on the stock in a report on Tuesday, June 16th. Finally, Zacks Research downgraded shares of Oxbridge Re from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 18th. One analyst has rated the stock with a Buy rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average price target of $3.00.

Institutional Trading of Oxbridge Re

A hedge fund recently bought a new position in Oxbridge Re stock. Citadel Advisors LLC purchased a new stake in Oxbridge Re Holdings Limited (NASDAQ:OXBR) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 65,855 shares of the insurance provider’s stock, valued at approximately $68,000. Citadel Advisors LLC owned approximately 0.81% of Oxbridge Re as of its most recent filing with the SEC. Hedge funds and other institutional investors own 5.64% of the company’s stock.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.